{"url":"https://lda.gov/api/v1/filings/33c716d1-96ff-4539-82c1-c38dc87d6d59/","filing_uuid":"33c716d1-96ff-4539-82c1-c38dc87d6d59","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/33c716d1-96ff-4539-82c1-c38dc87d6d59/print/","filing_document_content_type":"text/html","income":null,"expenses":"1810000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Rilliata Wilson","dt_posted":"2026-07-16T09:42:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"600 Massachusetts Ave, NW","registrant_address_2":"SUITE 300","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":15920,"url":"https://lda.gov/api/v1/registrants/15920/","house_registrant_id":31464,"name":"GENENTECH, INC","description":null,"address_1":"1399 NEW YORK AVENUE NW","address_2":"SUITE 300","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RILLIATA WILSON","contact_telephone":"+1 301-659-3596","dt_updated":"2026-07-17T10:39:20.211932-04:00"},"client":{"id":121523,"url":"https://lda.gov/api/v1/clients/121523/","client_id":12,"name":"GENENTECH INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-09"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to FDA and HHS program funding for the FY25 Labor, HHS, Education and Related Agencies, and FY25 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills Strategic National Stockpile (SNS) Funding and Oversight Funding for FDA e-labeling rule implementation Patient access to Part B medicineS Issues related to 340B program oversight Support for increased investments to address antimicrobial resistance Deficit reduction, reconciliation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66234,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"L","last_name":"SULKALA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66455,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":"MARIE","last_name":"CONNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143836,"prefix":"mrs","prefix_display":"MRS.","first_name":"VANESSA","nickname":null,"middle_name":"GANNON","last_name":"BURT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107300,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":"L.","last_name":"STOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77847,"prefix":null,"prefix_display":null,"first_name":"RAVI","nickname":null,"middle_name":null,"last_name":"UPADHYAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98298,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"SHOTZBERGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139297,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"COOLING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139256,"prefix":null,"prefix_display":null,"first_name":"CALEB","nickname":null,"middle_name":null,"last_name":"GRAFF","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152776,"prefix":"ms","prefix_display":"MS.","first_name":"KATHLEEN","nickname":null,"middle_name":"M.","last_name":"MCAULIFFE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152669,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153578,"prefix":null,"prefix_display":null,"first_name":"AMBER","nickname":null,"middle_name":null,"last_name":"COTTLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154260,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual property and process patent issues Patent litigation reforms PTAB and IPR processes Section 101 Reform Domestic and international compulsory licensing issues March-in Rights","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107300,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":"L.","last_name":"STOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153578,"prefix":null,"prefix_display":null,"first_name":"AMBER","nickname":null,"middle_name":null,"last_name":"COTTLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the 340B Drug Discount Program Issues relating to drug pricing Development of policies to advance antimicrobial research, antiviral research, and novel product development environment, including advancing new market incentives. Issues and policies relating to the Food and Drug Administration including biopharmaceutical development, drug safety and counterfeiting, and biosimilars. General education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to healthcare legislation Patient access to Part B medicines Issues related to health equity, diversity, and inclusion in clinical trials Issues related to advanced development and procurement of medical countermeasures (MCMs) Issues related to patient assistance and access Issues relating to privacy and securing the data of and personal information of consumers Issues relating to medical research data Issues relating to screening and diagnostics Issues related to public health preparedness and response Issues related to awareness about diabetic eye diseases in minority populations Issues related to public health preparedness. Issues related to access to drugs for minority communities Issues related to healthcare education and screening","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":98298,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"SHOTZBERGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107300,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":"L.","last_name":"STOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66455,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":"MARIE","last_name":"CONNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66234,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"L","last_name":"SULKALA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143836,"prefix":"mrs","prefix_display":"MRS.","first_name":"VANESSA","nickname":null,"middle_name":"GANNON","last_name":"BURT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77845,"prefix":null,"prefix_display":null,"first_name":"DAN","nickname":null,"middle_name":null,"last_name":"NEVES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139297,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"COOLING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77847,"prefix":null,"prefix_display":null,"first_name":"RAVI","nickname":null,"middle_name":null,"last_name":"UPADHYAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139256,"prefix":null,"prefix_display":null,"first_name":"CALEB","nickname":null,"middle_name":null,"last_name":"GRAFF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146054,"prefix":null,"prefix_display":null,"first_name":"ESTEVAN","nickname":null,"middle_name":null,"last_name":"SANTANA","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":82514,"prefix":null,"prefix_display":null,"first_name":"VALERIE","nickname":null,"middle_name":null,"last_name":"REYNOLDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149815,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"FRIEND","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152776,"prefix":"ms","prefix_display":"MS.","first_name":"KATHLEEN","nickname":null,"middle_name":"M.","last_name":"MCAULIFFE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152669,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153578,"prefix":null,"prefix_display":null,"first_name":"AMBER","nickname":null,"middle_name":null,"last_name":"COTTLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154261,"prefix":null,"prefix_display":null,"first_name":"ANIIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare and Medicaid coverage and reimbursement Issues related to the 340B Drug Discount Program Issues related to drug pricing Medicare reimbursement for biosimilars Issues related to CMMI","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66234,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"L","last_name":"SULKALA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66455,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":"MARIE","last_name":"CONNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143836,"prefix":"mrs","prefix_display":"MRS.","first_name":"VANESSA","nickname":null,"middle_name":"GANNON","last_name":"BURT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98298,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"SHOTZBERGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77847,"prefix":null,"prefix_display":null,"first_name":"RAVI","nickname":null,"middle_name":null,"last_name":"UPADHYAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139256,"prefix":null,"prefix_display":null,"first_name":"CALEB","nickname":null,"middle_name":null,"last_name":"GRAFF","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":146054,"prefix":null,"prefix_display":null,"first_name":"ESTEVAN","nickname":null,"middle_name":null,"last_name":"SANTANA","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":82514,"prefix":null,"prefix_display":null,"first_name":"VALERIE","nickname":null,"middle_name":null,"last_name":"REYNOLDS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139297,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"COOLING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77845,"prefix":null,"prefix_display":null,"first_name":"DAN","nickname":null,"middle_name":null,"last_name":"NEVES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152776,"prefix":"ms","prefix_display":"MS.","first_name":"KATHLEEN","nickname":null,"middle_name":"M.","last_name":"MCAULIFFE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153578,"prefix":null,"prefix_display":null,"first_name":"AMBER","nickname":null,"middle_name":null,"last_name":"COTTLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154260,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to R&D tax deductions and expense amortization Issues related to international taxation, including foreign-derived intangible income and interest deductions Issues related to supply chain incentives","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107300,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":"L.","last_name":"STOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66234,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"L","last_name":"SULKALA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77847,"prefix":null,"prefix_display":null,"first_name":"RAVI","nickname":null,"middle_name":null,"last_name":"UPADHYAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153578,"prefix":null,"prefix_display":null,"first_name":"AMBER","nickname":null,"middle_name":null,"last_name":"COTTLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues relating to trade policy and negotiations impacting the biopharmaceutical industry including the TRIPS IP Waiver Issues related to compulsory licensing of foreign patents Issues related to WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107300,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":"L.","last_name":"STOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153578,"prefix":null,"prefix_display":null,"first_name":"AMBER","nickname":null,"middle_name":null,"last_name":"COTTLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues related to public health protection including influenza development and preparedness Issues related to antimicrobial and antiviral research and product development Issues related to research and product development Issues related to drug development including PDUFA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143836,"prefix":"mrs","prefix_display":"MRS.","first_name":"VANESSA","nickname":null,"middle_name":"GANNON","last_name":"BURT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66455,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":"MARIE","last_name":"CONNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77845,"prefix":null,"prefix_display":null,"first_name":"DAN","nickname":null,"middle_name":null,"last_name":"NEVES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139297,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"COOLING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98298,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"SHOTZBERGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154260,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Drug pricing issues Prescription Drug User Fee Act reauthorization Issues related to prescription drug value Issues related to the 340B Drug Discount Program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66455,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":"MARIE","last_name":"CONNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143836,"prefix":"mrs","prefix_display":"MRS.","first_name":"VANESSA","nickname":null,"middle_name":"GANNON","last_name":"BURT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77847,"prefix":null,"prefix_display":null,"first_name":"RAVI","nickname":null,"middle_name":null,"last_name":"UPADHYAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98298,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"SHOTZBERGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139297,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"COOLING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66234,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"L","last_name":"SULKALA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152776,"prefix":"ms","prefix_display":"MS.","first_name":"KATHLEEN","nickname":null,"middle_name":"M.","last_name":"MCAULIFFE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152669,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154260,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOERPEL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Issues related to pharmaceutical supply chains Issues related to reporting on location of origin of pharmaceutical products Issues related to drug shortages Issues related to pharmaceutical manufacturing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107300,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":"L.","last_name":"STOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":77845,"prefix":null,"prefix_display":null,"first_name":"DAN","nickname":null,"middle_name":null,"last_name":"NEVES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98298,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"SHOTZBERGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153578,"prefix":null,"prefix_display":null,"first_name":"AMBER","nickname":null,"middle_name":null,"last_name":"COTTLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Issues relating to limits and restrictions on the immigration of high skilled workers Issues relating to the immigration of medical researchers","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107300,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":"L.","last_name":"STOLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66234,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"L","last_name":"SULKALA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":38,"name":"Labor, Dept of (DOL)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}